Expansile medullary glioma with mass effects on cm cistern ,adjacent cerebellar hemispheres & pontomedullary junction understanding with images & treatment plan

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching Images

medullary glioma MRI brainstem expansile mass

This diagnostic imaging panel consists of eight MRI slices (axial, sagittal, and coronal planes) demonstrating an expansile intra-axial mass in the brainstem, characteristic of a Diffuse Midline Glioma (DMG). The mass is primarily centered in the pons and exhibits a classic radiological profile: hypointense signal on T1-weighted pre-contrast (B, F) and post-contrast (A, E, G) sequences, indicating a lack of significant enhancement. T2-weighted (D, H) and FLAIR (C) sequences show the lesion as uniformly hyperintense. Anatomically, the tumor causes significant expansion of the pons, leading to the obliteration of the prepontine cistern and encasement of the basilar artery. Posteriorly, the mass compresses the fourth ventricle, though no proximal obstructive hydrocephalus is currently evident. Sagittal and coronal views (E, F, G, H) illustrate the longitudinal extent of the lesion, stretching from the pontomesencephalic junction superiorly to the pontomedullary junction inferiorly, with characteristically ill-defined, infiltrative borders. This series serves as a pedagogical example of the typical imaging features and local mass effect of pontine gliomas in neuro-oncology.

This diagnostic imaging panel consists of eight MRI slices (axial, sagittal, and coronal planes) demonstrating an expansile intra-axial mass in the brainstem, characteristic of a Diffuse Midline Glioma (DMG). The mass is primarily centered in the pons and exhibits a classic radiological profile: hypointense signal on T1-weighted pre-contrast (B, F) and post-contrast (A, E, G) sequences, indicating a lack of significant enhancement. T2-weighted (D, H) and FLAIR (C) sequences show the lesion as uniformly hyperintense. Anatomically, the tumor causes significant expansion of the pons, leading to the obliteration of the prepontine cistern and encasement of the basilar artery. Posteriorly, the mass compresses the fourth ventricle, though no proximal obstructive hydrocephalus is currently evident. Sagittal and coronal views (E, F, G, H) illustrate the longitudinal extent of the lesion, stretching from the pontomesencephalic junction superiorly to the pontomedullary junction inferiorly, with characteristically ill-defined, infiltrative borders. This series serves as a pedagogical example of the typical imaging features and local mass effect of pontine gliomas in neuro-oncology.

This sagittal T1-weighted fetal MRI scan demonstrates significant intracranial pathology in a developing fetus. The primary finding is a large, expansile, and poorly demarcated mass involving the brainstem, centered in the pons. The mass appears heterogeneously signal-intense and significantly expands the diameter of the pons, extending superiorly towards the midbrain and inferiorly toward the medulla. Secondary to this mass, there is evidence of severe obstructive hydrocephalus, characterized by marked dilation of the lateral ventricles and the third ventricle, with associated thinning of the overlying cerebral mantle and macrocephaly. The posterior fossa shows displacement of the cerebellar structures. This visual presentation is highly characteristic of a congenital brainstem glioma, specifically a diffuse intrinsic pontine glioma (DIPG) or similar anaplastic neoplasm, illustrating the typical obstructive complications and mass effect associated with neonatal neuro-oncology.

This sagittal T1-weighted fetal MRI scan demonstrates significant intracranial pathology in a developing fetus. The primary finding is a large, expansile, and poorly demarcated mass involving the brainstem, centered in the pons. The mass appears heterogeneously signal-intense and significantly expands the diameter of the pons, extending superiorly towards the midbrain and inferiorly toward the medulla. Secondary to this mass, there is evidence of severe obstructive hydrocephalus, characterized by marked dilation of the lateral ventricles and the third ventricle, with associated thinning of the overlying cerebral mantle and macrocephaly. The posterior fossa shows displacement of the cerebellar structures. This visual presentation is highly characteristic of a congenital brainstem glioma, specifically a diffuse intrinsic pontine glioma (DIPG) or similar anaplastic neoplasm, illustrating the typical obstructive complications and mass effect associated with neonatal neuro-oncology.

This diagnostic imaging composite displays two magnetic resonance imaging (MRI) sequences of the brain in a pediatric patient, illustrating a diffuse midline glioma affecting the brainstem. Image A is an axial T2-weighted sequence showing an expansile, infiltrative lesion located in the pons. The lesion demonstrates a heterogeneous signal intensity, with hyperintense focal areas (yellow arrow) indicative of cystic components or internal necrosis. The mass effect is evident as it expands the pontine contours. Image B is a sagittal, fat-saturated, T1-weighted sequence with gadolinium contrast enhancement. It reveals the solid portions of the tumor exhibit irregular, heterogeneous enhancement (yellow arrow), suggesting varying vascularity and blood-brain barrier disruption within the mass. The clinical presentation and imaging features are characteristic of a high-grade pediatric-type diffuse midline glioma, specifically the H3K27-altered molecular subtype. This case highlights the typical neuroradiological appearance of aggressive midline gliomas in children, focusing on expansile growth, signal heterogeneity, and variable contrast uptake.

This diagnostic imaging composite displays two magnetic resonance imaging (MRI) sequences of the brain in a pediatric patient, illustrating a diffuse midline glioma affecting the brainstem. Image A is an axial T2-weighted sequence showing an expansile, infiltrative lesion located in the pons. The lesion demonstrates a heterogeneous signal intensity, with hyperintense focal areas (yellow arrow) indicative of cystic components or internal necrosis. The mass effect is evident as it expands the pontine contours. Image B is a sagittal, fat-saturated, T1-weighted sequence with gadolinium contrast enhancement. It reveals the solid portions of the tumor exhibit irregular, heterogeneous enhancement (yellow arrow), suggesting varying vascularity and blood-brain barrier disruption within the mass. The clinical presentation and imaging features are characteristic of a high-grade pediatric-type diffuse midline glioma, specifically the H3K27-altered molecular subtype. This case highlights the typical neuroradiological appearance of aggressive midline gliomas in children, focusing on expansile growth, signal heterogeneity, and variable contrast uptake.

Multi-modal MRI series of the brain demonstrating a Diffuse Intrinsic Pontine Glioma (DIPG). (a) T1-weighted sagittal view shows an infiltrative, expansile mass centered within the pons. (b) Coronal T2-weighted images reveal the exophytic tumor portion extending into the prepontine and suprasellar cisterns, notably encasing the basilar artery. (c-e) Axial sequences highlight characteristic signal patterns: the lesion is hyperintense on T2-weighted (c) and Fluid-Attenuated Inversion Recovery (FLAIR) (d) sequences, indicating significant vasogenic edema or tumor infiltration. (e) Post-gadolinium T1-weighted axial sequence shows a conspicuous absence of enhancement, a typical feature of DIPG indicating an intact blood-brain barrier within the tumor. Associated secondary findings include obstructive hydrocephalus, evidenced by dilated lateral ventricles in the coronal views. This imaging series illustrates the classic neuroradiological criteria for pediatric brainstem gliomas, emphasizing anatomical distortion of the brainstem, cisternal extension, and specific signal characteristics across varying MRI sequences.

Multi-modal MRI series of the brain demonstrating a Diffuse Intrinsic Pontine Glioma (DIPG). (a) T1-weighted sagittal view shows an infiltrative, expansile mass centered within the pons. (b) Coronal T2-weighted images reveal the exophytic tumor portion extending into the prepontine and suprasellar cisterns, notably encasing the basilar artery. (c-e) Axial sequences highlight characteristic signal patterns: the lesion is hyperintense on T2-weighted (c) and Fluid-Attenuated Inversion Recovery (FLAIR) (d) sequences, indicating significant vasogenic edema or tumor infiltration. (e) Post-gadolinium T1-weighted axial sequence shows a conspicuous absence of enhancement, a typical feature of DIPG indicating an intact blood-brain barrier within the tumor. Associated secondary findings include obstructive hydrocephalus, evidenced by dilated lateral ventricles in the coronal views. This imaging series illustrates the classic neuroradiological criteria for pediatric brainstem gliomas, emphasizing anatomical distortion of the brainstem, cisternal extension, and specific signal characteristics across varying MRI sequences.

This composite of four magnetic resonance imaging (MRI) scans illustrates the diagnostic features of pediatric diffuse midline glioma in different anatomical locations. Panels A (axial) and B (sagittal) display T2-weighted sequences showing a large, hyperintense, and expansile mass involving the brainstem (pons), characteristic of a diffuse intrinsic pontine glioma (DIPG). The lesion demonstrates an infiltrative growth pattern, causing significant local mass effect and compression of adjacent structures. Panels C and D focus on a thalamic presentation. Panel C is an axial T2-weighted image showing a homogenous, hyperintense lesion within the right thalamus with poorly defined margins extending into the surrounding white matter tracts. Panel D shows the corresponding axial T1-weighted post-gadolinium sequence, revealing minimal to heterogeneous contrast enhancement within the thalamic mass. These images highlight key radiological hallmarks including the tumor's midline location, infiltrative nature, perilesional edema, and variable vascular permeability as indicated by enhancement patterns, which are critical for the clinical classification of these high-grade pediatric gliomas.

This composite of four magnetic resonance imaging (MRI) scans illustrates the diagnostic features of pediatric diffuse midline glioma in different anatomical locations. Panels A (axial) and B (sagittal) display T2-weighted sequences showing a large, hyperintense, and expansile mass involving the brainstem (pons), characteristic of a diffuse intrinsic pontine glioma (DIPG). The lesion demonstrates an infiltrative growth pattern, causing significant local mass effect and compression of adjacent structures. Panels C and D focus on a thalamic presentation. Panel C is an axial T2-weighted image showing a homogenous, hyperintense lesion within the right thalamus with poorly defined margins extending into the surrounding white matter tracts. Panel D shows the corresponding axial T1-weighted post-gadolinium sequence, revealing minimal to heterogeneous contrast enhancement within the thalamic mass. These images highlight key radiological hallmarks including the tumor's midline location, infiltrative nature, perilesional edema, and variable vascular permeability as indicated by enhancement patterns, which are critical for the clinical classification of these high-grade pediatric gliomas.

This composite of four images (A-D) presents a multi-modal MRI evaluation of a brainstem lesion. Panels (A) Coronal T2-weighted FLAIR and (B) Axial T2-weighted FLAIR demonstrate an ill-defined, hyperintense, and expansile mass within the right pons. The lesion extends into the right middle cerebellar peduncle and the right posterolateral medulla, causing partial effacement of the fourth ventricle. Panel (C) represents an axial post-gadolinium contrast T1-weighted image, which shows no contrast enhancement, indicating a preserved blood-brain barrier within the lesion. Panel (D) provides Magnetic Resonance Spectroscopy (MRS) data, showing a markedly increased choline (Cho) peak and a significantly decreased N-acetylaspartate (NAA) peak. This metabolic profile (high Cho:NAA ratio) is characteristic of increased cellular turnover and loss of neuronal integrity, typically seen in infiltrating gliomas such as Diffuse Intrinsic Pontine Glioma (DIPG). The findings are essential for neurosurgical and oncological education regarding the diagnostic imaging and metabolic characteristics of pediatric-type diffuse low-grade gliomas in adult patients.

This composite of four images (A-D) presents a multi-modal MRI evaluation of a brainstem lesion. Panels (A) Coronal T2-weighted FLAIR and (B) Axial T2-weighted FLAIR demonstrate an ill-defined, hyperintense, and expansile mass within the right pons. The lesion extends into the right middle cerebellar peduncle and the right posterolateral medulla, causing partial effacement of the fourth ventricle. Panel (C) represents an axial post-gadolinium contrast T1-weighted image, which shows no contrast enhancement, indicating a preserved blood-brain barrier within the lesion. Panel (D) provides Magnetic Resonance Spectroscopy (MRS) data, showing a markedly increased choline (Cho) peak and a significantly decreased N-acetylaspartate (NAA) peak. This metabolic profile (high Cho:NAA ratio) is characteristic of increased cellular turnover and loss of neuronal integrity, typically seen in infiltrating gliomas such as Diffuse Intrinsic Pontine Glioma (DIPG). The findings are essential for neurosurgical and oncological education regarding the diagnostic imaging and metabolic characteristics of pediatric-type diffuse low-grade gliomas in adult patients.

Searching PubMed

medullary glioma brainstem treatment

Reading File
Finding Sources
Finding Sources
Searching Images

cisterna magna cerebellomedullary cistern anatomy posterior fossa

This composite diagnostic image illustrates the cisterna magna across multiple modalities and planes. Panel A shows a sagittal view using 3D constructive interference in steady state (CISS) MRI, where the cistern appears as a dark, hypointense fluid-filled space. Panels B, C, and D utilize CT cisternography in axial, sagittal, and coronal planes, respectively, to visualize the cistern as a region of low attenuation enhanced by contrast material. Anatomically, the cisterna magna is located in the posterior cranial fossa, situated inferior to the cerebellum and posterior to the medulla oblongata. It is identified by arrows in each panel. The images demonstrate the cistern's relationship to surrounding structures, including the brainstem, cerebellar vermis, and the foramen magnum. This visual guide serves as a clinical reference for identifying normal subarachnoid cistern anatomy, which is essential for diagnosing conditions such as CSF rhinorrhea or posterior fossa malformations. The target audience includes medical students and radiology residents specializing in neuroimaging.

This composite diagnostic image illustrates the cisterna magna across multiple modalities and planes. Panel A shows a sagittal view using 3D constructive interference in steady state (CISS) MRI, where the cistern appears as a dark, hypointense fluid-filled space. Panels B, C, and D utilize CT cisternography in axial, sagittal, and coronal planes, respectively, to visualize the cistern as a region of low attenuation enhanced by contrast material. Anatomically, the cisterna magna is located in the posterior cranial fossa, situated inferior to the cerebellum and posterior to the medulla oblongata. It is identified by arrows in each panel. The images demonstrate the cistern's relationship to surrounding structures, including the brainstem, cerebellar vermis, and the foramen magnum. This visual guide serves as a clinical reference for identifying normal subarachnoid cistern anatomy, which is essential for diagnosing conditions such as CSF rhinorrhea or posterior fossa malformations. The target audience includes medical students and radiology residents specializing in neuroimaging.

A frontal P45 plastinated anatomical section of the human occipito-cervical junction (OCJ) passing through the posterior arch of the atlas (C1). The specimen demonstrates the morphological relationship between the cerebellum and the upper cervical spine. Key structures labeled include the tuber of vermis (VT) and tonsil of cerebellum (TOC) superiorly. The posterior cerebellomedullary cistern (PCC) is visible above the foramen magnum. A prominent, rhombic-shaped subarachnoid space (SS) is observed between the cerebellum and the atlas (C1), bordered by the arachnoid membrane (AM) and the spinal dura mater (indicated by arrows). Bony landmarks identified include the occipital bone (OCCI), the atlas (C1), and the axis (C2). The spinal cord (SC) is visible descending through the vertebral canal. The image illustrates the continuity of the subarachnoid space from the posterior cranial fossa into the upper cervical vertebral canal, highlighting the anatomy of the cisterna magna and the dural sac at the craniocervical transition. A metric ruler is included for scale.

A frontal P45 plastinated anatomical section of the human occipito-cervical junction (OCJ) passing through the posterior arch of the atlas (C1). The specimen demonstrates the morphological relationship between the cerebellum and the upper cervical spine. Key structures labeled include the tuber of vermis (VT) and tonsil of cerebellum (TOC) superiorly. The posterior cerebellomedullary cistern (PCC) is visible above the foramen magnum. A prominent, rhombic-shaped subarachnoid space (SS) is observed between the cerebellum and the atlas (C1), bordered by the arachnoid membrane (AM) and the spinal dura mater (indicated by arrows). Bony landmarks identified include the occipital bone (OCCI), the atlas (C1), and the axis (C2). The spinal cord (SC) is visible descending through the vertebral canal. The image illustrates the continuity of the subarachnoid space from the posterior cranial fossa into the upper cervical vertebral canal, highlighting the anatomy of the cisterna magna and the dural sac at the craniocervical transition. A metric ruler is included for scale.

**Imaging Modality:** Magnetic Resonance Imaging (MRI), Axial plane.

**Sequence:** Post-contrast T1-weighted image.

**Anatomical Region:** Posterior fossa and skull base, specifically focusing on the left cerebellomedullary cistern (cisterna magna), petrous apex, and mastoid air cells.

**Observed Findings:**
*   **Cisterna Magna:** A white arrow indicates the left cerebellomedullary cistern. There is a notable absence of a peripherally enhancing collection, signifying the resolution of a previously documented abscess.
*   **Skull Base and Mastoid:** Black arrows highlight persistent, though reduced, contrast enhancement within the left petrous apex and the mastoid air cells. These features are consistent with improving petrositis and mastoiditis.
*   **Cranial Nerves:** Normalization of contrast uptake in the vicinity of the lower cranial nerves is observed compared to previous involvement.

**Diagnostic Context:** Post-treatment follow-up of a skull base infection (likely secondary to otomastoiditis) with secondary intracranial extension. The image demonstrates therapeutic response characterized by the resolution of a focal infectious collection (abscess) while showing residual inflammatory changes in the adjacent osseous structures.

**Imaging Modality:** Magnetic Resonance Imaging (MRI), Axial plane. **Sequence:** Post-contrast T1-weighted image. **Anatomical Region:** Posterior fossa and skull base, specifically focusing on the left cerebellomedullary cistern (cisterna magna), petrous apex, and mastoid air cells. **Observed Findings:** * **Cisterna Magna:** A white arrow indicates the left cerebellomedullary cistern. There is a notable absence of a peripherally enhancing collection, signifying the resolution of a previously documented abscess. * **Skull Base and Mastoid:** Black arrows highlight persistent, though reduced, contrast enhancement within the left petrous apex and the mastoid air cells. These features are consistent with improving petrositis and mastoiditis. * **Cranial Nerves:** Normalization of contrast uptake in the vicinity of the lower cranial nerves is observed compared to previous involvement. **Diagnostic Context:** Post-treatment follow-up of a skull base infection (likely secondary to otomastoiditis) with secondary intracranial extension. The image demonstrates therapeutic response characterized by the resolution of a focal infectious collection (abscess) while showing residual inflammatory changes in the adjacent osseous structures.

Searching PubMed

diffuse midline glioma H3K27M radiation ONC201

Loading Image
Loading Image
Reading Article

PMID: 42317168

Reading Article

PMID: 39941789

Finding Sources
Searching Images

pontomedullary junction anatomy cerebellar hemispheres fourth ventricle diagram

This diagnostic image is an axial T2-weighted MRI of the brain at the level of the pons and fourth ventricle, illustrating neuroanatomical abnormalities characteristic of Möbius syndrome. The image reveals a bilateral absence of the facial colliculi in the dorsal pontine tegmentum, indicated by vertical arrows, leading to an atypical 'inverted V' shape of the fourth ventricle. Furthermore, there is a radiologic absence of the abducens nerves (Cranial Nerve VI) along their expected cisternal trajectory from the pontomedullary junction, marked by horizontal arrows. The surrounding middle cerebellar peduncles and cerebellar hemispheres appear otherwise intact. These findings—the absence of the facial colliculus (formed by facial nerve fibers looping around the abducens nucleus) and the lack of visible abducens nerves—are pathognomonic radiological signs of brainstem hypoplasia involving the VIth and VIIth cranial nerve nuclei, correlating with clinical symptoms of congenital facial paralysis and impaired lateral eye movement.

This diagnostic image is an axial T2-weighted MRI of the brain at the level of the pons and fourth ventricle, illustrating neuroanatomical abnormalities characteristic of Möbius syndrome. The image reveals a bilateral absence of the facial colliculi in the dorsal pontine tegmentum, indicated by vertical arrows, leading to an atypical 'inverted V' shape of the fourth ventricle. Furthermore, there is a radiologic absence of the abducens nerves (Cranial Nerve VI) along their expected cisternal trajectory from the pontomedullary junction, marked by horizontal arrows. The surrounding middle cerebellar peduncles and cerebellar hemispheres appear otherwise intact. These findings—the absence of the facial colliculus (formed by facial nerve fibers looping around the abducens nucleus) and the lack of visible abducens nerves—are pathognomonic radiological signs of brainstem hypoplasia involving the VIth and VIIth cranial nerve nuclei, correlating with clinical symptoms of congenital facial paralysis and impaired lateral eye movement.

**Imaging Modality:** Magnetic Resonance Imaging (MRI), Susceptibility-Weighted Imaging (SWI).

**Anatomical Region:** Axial section of the posterior fossa, specifically localized to the pontomedullary junction of the brainstem.

**Observed Pathology:** Capillary telangiectasia.

**Characteristic Visual Features:** The image demonstrates a focal area of signal loss (hypointensity) within the brainstem parenchyma, indicated by a white arrow. This "blooming" effect is characteristic of paramagnetic substances, such as deoxyhemoglobin or hemosiderin, within slow-flow vascular channels. The lesion exhibits a subtle, radiating "caput medusa" morphology, characterized by fine, brush-like peripheral vessels converging toward a central point. There is no evidence of surrounding edema or mass effect on the adjacent cerebellar hemispheres or fourth ventricle.

**Key Diagnostic Features:** The marked hypointensity on susceptibility-weighted sequences in an asymptomatic location is highly suggestive of a capillary telangiectasia. The lack of signal void on T1 or T2 sequences (not shown) and the presence of fine radiating vasculature help differentiate this from other vascular malformations like cavernous malformations or developmental venous anomalies (DVA).

**Imaging Modality:** Magnetic Resonance Imaging (MRI), Susceptibility-Weighted Imaging (SWI). **Anatomical Region:** Axial section of the posterior fossa, specifically localized to the pontomedullary junction of the brainstem. **Observed Pathology:** Capillary telangiectasia. **Characteristic Visual Features:** The image demonstrates a focal area of signal loss (hypointensity) within the brainstem parenchyma, indicated by a white arrow. This "blooming" effect is characteristic of paramagnetic substances, such as deoxyhemoglobin or hemosiderin, within slow-flow vascular channels. The lesion exhibits a subtle, radiating "caput medusa" morphology, characterized by fine, brush-like peripheral vessels converging toward a central point. There is no evidence of surrounding edema or mass effect on the adjacent cerebellar hemispheres or fourth ventricle. **Key Diagnostic Features:** The marked hypointensity on susceptibility-weighted sequences in an asymptomatic location is highly suggestive of a capillary telangiectasia. The lack of signal void on T1 or T2 sequences (not shown) and the presence of fine radiating vasculature help differentiate this from other vascular malformations like cavernous malformations or developmental venous anomalies (DVA).

This composite figure displays postoperative and follow-up neuroimaging of a 66-year-old patient following surgical resection of neurocysticercosis. Panel (A) is an axial non-contrast head CT demonstrating the posterior fossa. Key features include the brainstem, cerebellum, and a centrally located fourth ventricle, with postoperative changes visible in the right cerebellar hemisphere indicating successful cyst removal. Panel (B) shows an axial T1-weighted brain MRI at the 2-year follow-up, confirming the absence of parasitic cyst recurrence. Panel (C) is a coronal T2-weighted brain MRI illustrating the posterior fossa anatomy and supratentorial brain parenchyma. This sequence highlights the cerebrospinal fluid (CSF) spaces, including the lateral and fourth ventricles. A hyperintense signal area at the pontomedullary junction suggests a CSF fistula, a known postoperative complication. The images collectively demonstrate the radiological assessment of treatment success for neurocysticercosis and the identification of long-term postoperative sequelae in a clinical neurosurgical context.

This composite figure displays postoperative and follow-up neuroimaging of a 66-year-old patient following surgical resection of neurocysticercosis. Panel (A) is an axial non-contrast head CT demonstrating the posterior fossa. Key features include the brainstem, cerebellum, and a centrally located fourth ventricle, with postoperative changes visible in the right cerebellar hemisphere indicating successful cyst removal. Panel (B) shows an axial T1-weighted brain MRI at the 2-year follow-up, confirming the absence of parasitic cyst recurrence. Panel (C) is a coronal T2-weighted brain MRI illustrating the posterior fossa anatomy and supratentorial brain parenchyma. This sequence highlights the cerebrospinal fluid (CSF) spaces, including the lateral and fourth ventricles. A hyperintense signal area at the pontomedullary junction suggests a CSF fistula, a known postoperative complication. The images collectively demonstrate the radiological assessment of treatment success for neurocysticercosis and the identification of long-term postoperative sequelae in a clinical neurosurgical context.

Loading Image
Loading Image
Finding Sources
Finding Sources
Reading File
Loading Image
Loading Image

Expansile Medullary Glioma: Mass Effect on CM Cistern, Cerebellar Hemispheres & Pontomedullary Junction


1. Anatomical Context - Understanding the Region

The Cerebellomedullary (CM) Cistern (Cisterna Magna)

The cisterna magna is the largest subarachnoid cistern in the posterior cranial fossa. It lies inferior to the cerebellar vermis and posterior to the medulla oblongata, bounded posteriorly by the posterior atlanto-occipital membrane and inferiorly by the foramen magnum. It receives CSF from the 4th ventricle via the foramina of Luschka and Magendie, and communicates freely with the spinal subarachnoid space.
Cisterna magna anatomy - sagittal 3D CISS MRI (Panel A) and CT cisternography (Panels B-D) showing the cistern inferior to the cerebellum, posterior to the medulla oblongata, and its relationship to surrounding structures
When a medullary glioma expands posteriorly and inferiorly, it directly encroaches on this cistern - obliterating its normal CSF space, compressing the foramina of Magendie, and potentially blocking CSF outflow to cause non-communicating or communicating hydrocephalus.

The Pontomedullary Junction (PMJ)

The PMJ is the transition zone between the pons superiorly and medulla oblongata inferiorly. Key structures here include:
  • Cranial nerve VI nuclei (abducens) just above
  • Cranial nerve VII (facial) looping around CN VI in the facial colliculus
  • Cranial nerve IX, X, XI, XII originating from the medulla
  • Pyramidal tracts and medial lemniscus passing through
  • Middle and inferior cerebellar peduncles connecting brainstem to cerebellar hemispheres
Mass effect at this junction produces the classic triad: lower cranial neuropathies + long-tract signs + cerebellar signs.

2. Pathology and Classification

What is a Medullary Glioma?

Medullary gliomas are infiltrating glial tumors arising within the medulla oblongata. They fall under the broad category of brainstem gliomas, which are now molecular-genetically classified rather than anatomically alone (WHO 2021):
ClassificationKey Features
Diffuse Midline Glioma, H3K27-alteredH3K27M mutation in histone 3; most aggressive; includes DIPG and medullary variants
Diffuse Astrocytoma (IDH-mutant, grade 2-3)Rare in medulla; IDH1 mutations in ~80% of adult DAs
Focal/Nodular Pilocytic AstrocytomaDorsal exophytic type; better prognosis; often enhancing cystic mural nodule
Cervicomedullary gliomaStraddles medulla and upper cervical cord; often low-grade in children

Expansile Growth Pattern - Two Subtypes

1. Diffuse Infiltrating Type (most common, worst prognosis)
  • Asymmetric enlargement of the medulla/pons
  • Hypointense T1, heterogeneously hyperintense T2/FLAIR
  • Poor margins; engulfs cranial nerve nuclei and tracts
  • Minimal or no gadolinium enhancement (intact blood-brain barrier in low-grade)
  • Displaces and encroaches on cisterns and adjacent structures
  • H3K27M mutation common
2. Focal/Dorsally Exophytic Type (better prognosis)
  • Grows out of the dorsal medullary surface into the CM cistern
  • May look like an extra-axial mass on imaging
  • Often pilocytic histology; may enhance with contrast
  • Surgical resection sometimes feasible
  • Long-term survivors documented
Adams & Victor's Principles of Neurology, 12th Ed. distinguishes these subtypes, noting that "focal or nodular tumors tend to occur in the dorsal brainstem and often protrude in an exophytic manner" with a better prognosis than diffusely infiltrating tumors.

3. MRI Imaging - Features & Mass Effect

Characteristic MRI Findings

T1-weighted: Hypointense expansion of the medulla; obliteration of normal medullary anatomy
T2/FLAIR: Hyperintense signal reflecting tumor infiltration and edema
Gadolinium (T1+C): Variable - diffuse type typically non-enhancing; exophytic/focal type may show ring or nodular enhancement
DWI: Usually restricted diffusion in high-grade variants
MR Spectroscopy: Elevated Cho:NAA ratio - high choline (increased cell turnover), reduced NAA (neuronal loss)
Multi-panel MRI of diffuse midline glioma: T1 post-contrast (A,B,E,G) showing no enhancement, T2/FLAIR (C,D,H) showing expansile hyperintense pons/medulla. Mass obliterates prepontine cistern and encases basilar artery, stretching from pontomesencephalic to pontomedullary junction
Axial T2 and sagittal post-contrast MRI showing expansile brainstem glioma (yellow arrows): heterogeneous signal, cystic components, irregular enhancement in high-grade subtype. Note massive posterior fossa involvement

MRI Spectrum of Mass Effect on Specific Structures

StructureMass Effect Observed
CM cisternObliteration of posterior CSF space; dorsal exophytic component may fill/displace cistern
Cerebellar hemispheresDirect compression via inferior/middle cerebellar peduncles; displaced laterally and posteriorly
Pontomedullary junctionLoss of normal brainstem contours; engulfment of CN nuclei VI, VII; trapped basilar artery
4th ventricleCompression from below/anteriorly → obstructive hydrocephalus
Foramen magnumInferior extension may cause cervicomedullary syndrome
Textbook MRI from Bradley & Daroff's: 4-year-old girl, dorsally exophytic medullary mass (panels A,B axial and sagittal T2-FLAIR); and a 5-year-old, diffuse pontine glioma with basilar artery encasement (panel C)
MRI + MR Spectroscopy composite of posterior fossa diffuse glioma: coronal FLAIR (A), axial T2 (B), axial post-contrast T1 (C), MRS (D) showing classic elevated Cho and depressed NAA peaks characteristic of infiltrating glioma

4. Clinical Presentation

The clinical syndrome depends on the structures compressed or infiltrated:

From Medullary Involvement

  • Dysphagia (CN IX, X nuclei)
  • Hoarseness and dysphonia (nucleus ambiguus)
  • Hiccups, nausea, early satiety - tegmental medullary involvement near the dorsal vagal nucleus and area postrema
  • Respiratory irregularities - pre-Botzinger complex

From Pontomedullary Junction Mass Effect

  • Ipsilateral CN VI palsy (diplopia, lateral gaze failure)
  • Ipsilateral CN VII palsy (peripheral facial weakness)
  • Contralateral hemiparesis (corticospinal tract compression - crossed signs)
  • Hemisensory deficits (medial lemniscus)
  • Nystagmus, vertigo (vestibular nuclei)

From Cerebellar Hemisphere Compression

  • Ipsilateral limb ataxia (dentate-thalamic pathway disruption)
  • Dysmetria, dysdiadochokinesia
  • Wide-based unsteady gait

From CM Cistern Obliteration / 4th Ventricle Compromise

  • Raised intracranial pressure: Headache (morning, positional), vomiting, papilledema
  • Obstructive hydrocephalus (late sign)
  • Downward Herniation Risk if craniocervical mass extends inferiorly
Adams & Victor's Neurology notes: "Patients with medullary tumors may present with a long history of dysphagia, hoarseness, ataxia, and hemiparesis. Cervicomedullary tumors may cause medullary or upper cervical symptoms, neck discomfort, weakness or numbness of the hands, and asymmetrical quadriparesis."

5. Molecular Biology - The H3K27M Mutation

A central discovery in brainstem/midline gliomas was the H3K27M gain-of-function mutation in histone 3 (H3.3 or H3.1), occurring in ~80% of DIPGs and medullary diffuse midline gliomas.
Consequences:
  • Inhibits Polycomb Repressive Complex 2 (PRC2), reducing global H3K27 trimethylation
  • Leads to widespread epigenetic dysregulation and transcriptional activation of oncogenes
  • Confers WHO Grade 4 behavior regardless of histological appearance
  • Strongly associated with poor prognosis (median OS ~9-11 months from diagnosis)
  • Diagnostic: H3K27M IHC on biopsy confirms Diffuse Midline Glioma (DMG) classification
Other relevant mutations: ACVR1 (BMP pathway), PDGFRA amplification, TP53, PPM1D.

6. Treatment Plan

Step 1: Diagnosis Confirmation

  • MRI brain + spine with gadolinium (full neuraxis staging)
  • Stereotactic biopsy - now standard even for posterior fossa/brainstem lesions; yields molecular diagnosis (H3K27M, IDH1/2, BRAF, FGFR status)
  • LP for CSF cytology if leptomeningeal spread suspected
  • Ophthalmology for papilledema assessment

Step 2: Management of Mass Effect / Raised ICP

SituationIntervention
Obstructive hydrocephalusEndoscopic 3rd ventriculostomy (ETV) or VP shunt
Acute neurological deteriorationIV dexamethasone (0.5-1 mg/kg/day); osmotic therapy if needed
Dorsally exophytic component accessibleSurgical debulking/resection of exophytic portion (subtotal resection possible)
Diffuse infiltrating typeSurgery NOT indicated as primary treatment; biopsy only
Adams & Victor's: "Treatment of the diffuse infiltrative type has generally been radiation, and if increased ICP develops as a result of hydrocephalus, ventricular shunting of CSF becomes necessary."

Step 3: Radiation Therapy - The Primary Treatment

Standard: Focal radiation therapy (RT) to the tumor with margin
  • Dose: 54 Gy in 30 fractions (1.8 Gy/fraction) for standard fractionation
  • Alternative: Hypofractionated RT (39 Gy in 13 fractions) for very young children (<3 years) or palliation
  • Field: Involved field RT (IFRT); whole-brain RT only if leptomeningeal disease
  • Response: ~80-90% of patients show temporary clinical improvement; median duration 6-9 months
  • Re-irradiation: At recurrence, re-RT (24-30 Gy) provides meaningful palliation in selected patients; craniospinal irradiation for leptomeningeal disease
Per Lo Greco et al., 2025 in Cancers: "Identifying the H3K27M mutation can help explore how genetic changes affect treatment response, recurrence patterns, and survival... a slightly higher dose could be used for the second round of local irradiation. Irradiating the entire craniospinal axis could help control both local and leptomeningeal disease."

Step 4: Systemic Therapy

A. Dordaviprone (ONC201) - FDA Approved 2024 (Recurrent H3K27M DMG)

  • Mechanism: Dopamine receptor D2/D3 antagonist + ClpP mitochondrial protease activator; inhibits Akt/ERK kinases; epigenetically reprograms tumor microenvironment
  • FDA approval: Accelerated approval for recurrent/progressive H3K27M DMG in adults and children ≥6 months (2024)
  • Evidence: Phase 1/2 trials - ORR 20%, disease control rate 40%, median duration of response 11.2 months
  • Dosing: 375 mg once weekly orally
  • Side effects: Fatigue, headache, vomiting, nausea (generally well tolerated)
  • Current status: NOT a substitute for radiation; used at recurrence. The ACTION trial is evaluating it in newly diagnosed H3K27M DMG
Per Nuss et al., J Oncol Pharm Pract 2026: "Dordaviprone demonstrates long-lasting radiographic and symptomatic improvement... The ACTION trial may provide guidance on its broader use in newly diagnosed H3K27M DMG."

B. Other Systemic Options

AgentClassStatus
PanobinostatHDAC inhibitor (epigenetic)Phase I/II trials; promising in H3K27M
Nimotuzumab + VinorelbineAnti-EGFR + vinca alkaloidPhase II evidence; combination used post-RT
BRAF/MEK inhibitors (dabrafenib + trametinib)Targeted therapyFor BRAF V600E-mutant pilocytic/focal gliomas
BRAF + MEK inhibitorsTargetedBRAF-mutant DA with early malignant transformation
CAR-T cell therapyImmunotherapyGD2-directed CAR-T (H3K27M): early phase trials; CSF delivery
Convection-enhanced delivery (CED)Local drug deliveryDirect brainstem infusion bypassing BBB; experimental
Oncolytic viruses (DNX-2401)VirotherapyPreliminary series show possible prolonged survival

C. Conventional Chemotherapy

  • Adjuvant chemotherapy has generally not been helpful for diffuse infiltrating brainstem gliomas
  • Temozolomide: No survival benefit in DIPG/medullary diffuse type (multiple failed trials)
  • May be considered for IDH-mutant variants in adults (similar to supratentorial DAs)

Step 5: Supportive & Palliative Care

  • Dexamethasone: Titrate to lowest effective dose; long-term side effects (Cushingoid features, hyperglycemia, myopathy)
  • Antiepileptics: If seizures develop
  • Nutritional support: Dysphagia management; PEG tube if aspiration risk
  • Speech and swallowing therapy
  • Physical and occupational therapy: Manage ataxia and hemiparesis
  • Palliative care integration: Early referral; goals-of-care discussions given poor prognosis

7. Prognosis

Tumor TypeMedian OSNotes
Diffuse infiltrating medullary/DIPG (H3K27M)9-15 monthsWorst prognosis group
Diffuse infiltrating (H3K27 wild-type)15-24 monthsSlightly better
Focal dorsally exophytic (pilocytic)5-10 yearsBest prognosis; surgical candidates
IDH-mutant diffuse astrocytoma (adult)5-10+ yearsSlower progression
Cervicomedullary (low-grade)3-7 yearsDepends on extent of resection
Factors predicting longer survival: dorsally exophytic growth, long symptom duration before diagnosis, focal (non-diffuse) imaging, absence of H3K27M, younger age (paradoxically worse in children with DIPG vs adults), and normal-range leptomeningeal spread at diagnosis.

8. Summary Algorithm

Posterior fossa mass on imaging
        ↓
Medullary location? → MRI with gadolinium (brain + spine)
        ↓
Morphology assessment
    ├── Diffuse/infiltrating? → Biopsy only → Molecular profiling
    │           ↓
    │   H3K27M+ → Diffuse Midline Glioma (WHO Grade 4)
    │   → Focal RT 54 Gy + Dordaviprone at recurrence
    │
    └── Focal/exophytic? → Surgical exploration
                ↓
        Resection of exophytic mural nodule
        → RT if residual/progressive
        → Targeted therapy if BRAF-mutant
        ↓
Hydrocephalus? → ETV or VP shunt
Raised ICP? → Dexamethasone ± osmotherapy
Leptomeningeal? → Consider craniospinal RT

Key Sources:
This is a shared conversation. Sign in to Orris to start your own chat.